As of Apr 20
| +0.31 / +1.71%|
The 5 analysts offering 12-month price forecasts for Epizyme Inc have a median target of 42.00, with a high estimate of 45.00 and a low estimate of 23.00. The median estimate represents a +127.27% increase from the last price of 18.48.
The current consensus among 6 polled investment analysts is to Buy stock in Epizyme Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.